VIDEO: Aflibercept shows improvement across baseline factors in PANORAMA study

ByNathan C. Steinle, MD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

In this video perspective from the virtual AAO annual meeting, Nathan C. Steinle, MD, discusses results from the PANORAMA study in patients with nonproliferative diabetic retinopathy.

Published by:

Sources/Disclosures

Collapse

Source:

Steinle N. Intravitreal aflibercept injection in moderately severe to severe NPDR: Treatment effect by baseline factors in PANORAMA. Presented at: American Academy of Ophthalmology annual meeting; Nov. 13-15, 2020 (virtual meeting).

Read more about

diabetic macular edema

aflibercept

macular degeneration

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment